Possible role of HMG-CoA reductase inhibitors for the treatment of sudden sensorineural hearing loss (SSHL)

Medical Hypotheses

Volumn 58, Issue 5, 2002, Pages 399-402

  Borghi, C ^a   Modugno, G C ^a   Pirodda, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; THROMBOXANE A2;

ARTERY DILATATION; ARTICLE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; HEMODYNAMICS; HUMAN; PATHOGENESIS; PERCEPTION DEAFNESS; PRIORITY JOURNAL; VIRUS INFECTION; BIOLOGICAL MODEL; COCHLEA; PATHOPHYSIOLOGY; PHYSIOLOGY; SUDDEN DEAFNESS;

COCHLEA; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MODELS, BIOLOGICAL; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; THROMBOXANE A2;

EID: 0036020689     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2001.1535     Document Type: Article

References (16)

1. Natural history of sensorineural hearing loss
2. Can hypotension episodes cause cochlear damage in young subjects?
3. The role of hypotension in the pathogenesis of sudden hearing loss
4. Hypotension and sensorineural hearing loss: A possible correlation
5. Autonomic nervous system and hearing
6. Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus
7. Die spontanremission beim hörsturz
8. Current perspectives on statins
9. The evolving role of statins in the management of atherosclerosis
10. Up-regulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors
11. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of Rho GTPase gene transcription
12. Antiatherothrombotic properties of statins: Implications for cardiovascular events reduction
13. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men
14. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia
15. Use of statins and blood pressure control in hypertensive patients with hypercholesterolemia
16. Statins and blood pressure regulation